Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Why are Clinical Trials important?

Before a new treatment is tested in patients, it is carefully studied in the laboratory. First, a drug is considered because it changes cells or parts of cells in a way that suggests it will destroy cancer or help the body to deal with the side effects of cancer treatment. Then, the new treatment is tested in animals to learn what it does in the body. But this early research cannot predict exactly how a new treatment will work in people or define all the side effects that might occur. Clinical Trials are designed to help us find out how to give a new treatment safely and effectively to people. Each patient who participates in a Clinical Trial provides information on the effectiveness and risks of the new treatment. Advances in medicine and science are the result of new ideas and approaches developed through research. New cancer treatments must prove to be safe and effective in scientific studies with a certain number of patients before they can be made available to all patients.

Treatments now being used (standard treatments) are the base for building new, hopefully better, treatments. Many standard treatments were first shown to be effective in Clinical Trials. Clinical Trials show researchers which therapies are more effective than others. This is the best way to identify an effective new treatment. New therapies are designed to take advantage of what has worked in the past and to improve on this base.

You may be interested in participating in a trial. You should learn as much as you can about the trial before you make up your mind.

Clinical Trials are the most reliable and best way of testing a new treatment, or of seeing whether one treatment works better than another. A new treatment is not always better, and can sometimes be worse than existing treatments. Trials are therefore really important when we need to know whether one treatment is safer and more effective than another.

We need Clinical Trials to improve treatment and care for patients now and in the future.

Many of the treatments now commonly used in the NHS have been tested through Clinical Trials. For example, in cancer care, trials have been used to try out new treatments – radiotherapy, chemotherapy, surgery, and complementary therapies. Trials have also been used to find out the best ways of using these treatments. This has meant that many people with cancer, HIV/AIDS and many other illnesses live longer and have a better quality of life.

Useful Medical Trial information

News

Type 2 diabetes: Blood sugar pill shows promise

In a 26-week phase II clinical trial for type 2 diabetes patients, glycemic control using semaglutide in pill form was better than using a placebo. Powered by WPeMatico

more >

Cannabis intoxication may be stopped with anti-obesity drug

Intoxication with so-called legal highs may be fatal. But new research may have found the antidote in a slimming drug that blocks cannabinoid receptors. Powered by WPeMatico

more >

Heart failure could be treated using umbilical cord stem cells

In the first study of its kind, researchers find that stem cells derived from the umbilical cord can be used to treat heart failure. Powered by WPeMatico

more >

Poliovirus kills off cancer cells, stops tumor regrowth

A modified poliovirus appears to trigger the body’s anti-tumor immunity. The new study showed promising results in human breast cancer cells and mice. Powered by WPeMatico

more >

Drug resistance: WHO report ‘serious lack of new antibiotics’

A new report from the WHO reveals that the current scope of new antibiotic development is far from what is needed to tackle drug resistance. Powered by WPeMatico

more >

Kyowa Hakko Kirin joins Certara’s Simcyp consortium

Certara, a provider of model-informed drug development and regulatory science, announced that Kyowa Hakko Kirin has joined the Simcyp Consortium and licensed the Simcyp Population-based Simulator. Kyowa Hakko Kirin is the 36th leading biopharmaceutical company and the 11th Japanese pharmaceutical company to join the Consortium. Member companies meet in a pre-competitive environment and work together to […]

more >